Germany’s switch committee, the SVA, remains unconvinced with regards to the OTC availability of erectile dysfunction drugs sildenafil and tadalafil, as evidenced by the recently published full minutes of its last meeting on 11 July.
Despite the best efforts of the unnamed switch applicants, and against a backdrop of widening OTC access elsewhere, ED sufferers...